I
1.09
0.00 (0.00%)
| 前收盘价格 | 1.09 |
| 收盘价格 | 1.11 |
| 成交量 | 38,059 |
| 平均成交量 (3个月) | 1,865,078 |
| 市值 | 49,883,960 |
| 价格/销量 (P/S) | 1.80 |
| 股市价格/股市净资产 (P/B) | 2.88 |
| 52周波幅 | |
| 利润日期 | 28 Jul 2025 - 1 Aug 2025 |
| 营业毛利率 | -194.79% |
| 营业利益率 (TTM) | -53.47% |
| 稀释每股收益 (EPS TTM) | -1.23 |
| 季度收入增长率 (YOY) | -1.10% |
| 总债务/股东权益 (D/E MRQ) | 51.46% |
| 流动比率 (MRQ) | 2.32 |
| 营业现金流 (OCF TTM) | -7.91 M |
| 杠杆自由现金流 (LFCF TTM) | -3.63 M |
| 资产报酬率 (ROA TTM) | -14.88% |
| 股东权益报酬率 (ROE TTM) | -124.75% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | ImmunoPrecise Antibodies Ltd. | 看跌 | 看跌 |
AIStockmoo 评分
0.8
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -5.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.75 |
|
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 5.21% |
| 机构持股比例 | 8.59% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Cibc World Market Inc. | 31 Mar 2025 | 41,200 |
| Thoroughbred Financial Services, Llc | 31 Mar 2025 | 40,000 |
| Gradient Capital Advisors, Llc | 31 Mar 2025 | 26,808 |
| 52周波幅 | ||
| 中 | 5.00 (358.72%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 11 Apr 2025 | 5.00 (358.72%) | 购买 | 0.431 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合